Bottom line: Postal Savings Bank’s IPO is likely to get a moderately strong reception and come close to the upper end of its $10 billion target, while Yum China’s IPO is unlikely to come until the end of this year at earliest.
Yum China spin off plans hit delays
What’s likely to become the world’s biggest IPO in 2 years has just officially launched in Hong Kong, with word that China’s Postal Savings Bank has made its first filing for an offering that could raise up to $10 billion. Meantime, another high-profile IPO by the Chinese unit of fast-food giant Yum Brands (NYSE: YUM) is getting hit by delays, as operator of the KFC chain seeks key local backers in the run-up to a listing that could also come in Hong Kong. The Yum offering could also be quite large at around $2 billion, though it appears the deal may not come now until the end of this year or may even get pushed back to 2017. Read Full Post…
Bottom line: 21Vianet could get a new privatization offer from Tsinghua Unigroup by year end, following withdrawal of a previous bid; while Xiaomi chief Lei Jun may start selling non-core assets to raise money for his struggling company.
Buyout group scraps 21Vianet bid
Data center operator 21Vianet (Nasdaq: VNET) has finally done the inevitable and formally scrapped its de-listing plan, becoming the second company to do so among some 40 US-listed Chinese firms trying to privatize from New York. This particular move has been coming for a while now, and signs appeared as early as May that 21Vianet was abandoning its privatization plans. But new Chinese media reports are casting some light on why this particular bid collapsed, and it appears the reasons are linked to struggling smartphone maker Xiaomi, whose chief and co-founder Lei Jun was helping to finance the deal. Read Full Post…
The following press releases and news reports about China companies were carried on July 1. To view a full article or story, click on the link next to the headline.
══════════════════════════════════════════════
China’s Postal Savings Bank Files for Potential $10 Bln IPO (English article)
21Vianet (Nasdaq: VNET) Announces Withdrawal of Going Private Proposal (GlobeNewswire)
Bank of China (HKEx: 3988) to Sell Assets to HK Unit for $887 Mln (English article)
Shenzhen Businessman Buys Australian Soccer Club Newcastle United Jets (Chinese article)
Billionaire Wang’s Bid for Global Theater Behemoth Falters (English article)
Bottom line: Smartisan is likely to close or get sold by the end of this year, possibly to Meizu, while Xiaomi’s valuation is likely to fall by up to half when it returns to private investors for new funding with a year.
No near-term IPO for Xiaomi
A couple of fund-raising stories involving smartphone makers Smartisan and Xiaomi are in the headlines, reflecting in different ways the intense pressure each is feeling due to stiff competition that could soon claim a major victim. One headline has everyone buzzing over a recent share sale to raise cash by the founder of Smartisan, a highbrow niche brand set up by China’s most famous English teacher Luo Yonghao. The other has Xiaomi chief Lei Jun saying that his company may make an IPO in 2025, in what looks like a sarcastic response to a reporter’s question. Read Full Post…
Bottom line: Orient Securities IPO shares will debut flat due to weakness in China’s stock markets, CR Pharma will price stronger on good prospects for drug makers, and Wanda Commercial will have to raise its privatization buyout price.
CR Pharma files for HK IPO
After a quiet first half of the year, big IPOs for Chinese companies are suddenly coming to life in Hong Kong, though the outlook isn’t particularly strong. The latest headlines have China Resources Pharmaceutical filing for a $1 billion offering that was first mooted back in February, while the second has Oriental Securities pricing its own $1 billion offering near the bottom of its range. Meantime, a privatization bid for the Hong Kong-listed Wanda Commercial Properties (HKEx: 3699) has hit a stumbling block, with word that a major investor has objected that the buyout price is too low. Read Full Post…
Bottom line: Baidu will suffer more damage to its revenue and profits after new actions by China’s Cyberspace Administration, creating a potential opportunity for Bing or even Yahoo in China’s lucrative search market.
Baidu’s search woes offer opportunity for Bing, Yahoo
The woes for Internet search giant Baidu (Nasdaq: BIDU) continue, with word that China’s Internet censor is ordering the already hobbled company to cleanse itself of inappropriate sites in its search results. But whereas previous crackdowns have focused on politically sensitive content, this latest crackdown focuses on sites of companies that may be engaged in fraud or making inflated or bogus claims. The entire situation looks set to make a major dent in Baidu’s growth story, and could even see the company’s revenue shrink as it finds a new equilibrium.Read Full Post…
The following press releases and news reports about China companies were carried on June 30. To view a full article or story, click on the link next to the headline.
══════════════════════════════════════════════
China Resources Pharmaceutical Launches HK IPO, Aims to Raise up to $1 Bln (Chinese article)
Kuka (Frankfurt: KU2) Management Approves Sale to Midea (Shenzhen: 000333) (Chinese article)
Wanda Property (HKEx: 3699) Deal Faces Hurdles as APG Balks Over Price (English article)
Bottom line: Washington’s 2 month extension of a temporary license for ZTE to keep buying from its US suppliers indicates a final ruling is likely by year end in a similar probe against Huawei for illegally selling US products to Iran.
US extends export license for ZTE
After a tense period earlier this year when it appeared it could lose access to some of its key suppliers, telecoms equipment maker ZTE (HKEx: 763; Shenzhen: 000063) has been given continued access to those suppliers under a new extension of its earlier deal with Washington. The clash stemmed from a Washington ruling that ZTE sold US-manufactured telecoms equipment to Iran in violation of trade restrictions. Washington was set to punish ZTE by cutting it off from its many US suppliers, but later relented after the Chinese company agreed to cooperate with an investigation into the matter. Read Full Post…
Bottom line: Goldman’s bet on Minsheng Bank could auger a new wave of foreign investment in depressed Chinese bank shares, on belief that Beijing will rescue the group before their bad debt becomes too heavy.
Goldman invests in Minsheng
After dumping shares of major Chinese lenders in droves after the global financial crisis, at least one major foreign investor is testing the waters again, with word that Goldman Sachs (NYSE: GS) has quietly built up a large stake in Minsheng Bank (HKEx: 1988; Shanghai: 600016). But this time Goldman’s move, which has seen it quietly buy 11 percent of Minsheng’s Hong Kong-listed shares, looks likely a pure investment play rather than a strategic tie-up. Read Full Post…
Bottom line: Reports of big sales target reductions could point to a looming slowdown for Huawei, as it tries to move out of low-end smartphones and into an increasingly saturated higher end of the market.
Huawei set for slowdown?
After posting phenomenal growth over the last year to become the world’s third biggest smartphone brand, China’s Huawei may be seeing a slowdown that’s reportedly prompting it to sharply cut its sales targets for this year. If the reports are true, the downward revision would mark a sudden reversal for Huawei, which has been posting sales growth in the 50-60 percent range since the middle of last year when its recent surge began. Such a shift would hardly be unprecedented in the fast-changing smartphone world, though it would come as a slight surprise since the company’s phones have become quite popular here in China, approaching the status of global superstar Apple (Nasdaq: AAPL). Read Full Post…
The following press releases and news reports about China companies were carried on June 29. To view a full article or story, click on the link next to the headline.
══════════════════════════════════════════════
Yum (NYSE: YUM) China Stake Sale Said Delayed as Suitors Miss Deadline (English article)
Pfizer (NYSE: PFE) to Invest $350 Mln in China Biotech Hub, First in Asia (English article)
Fosun (HKEx: 656) Plans to List US Insurer Ironshore ‘As Soon As Possible’ (English article)
ZTE (HKEx: 763) Says Temporary License Extended for Import of US Goods (HKEx announcement)
